Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

PCOS has no cure, but treatments can manage symptoms and improve health.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Minoxidil's absorption is too variable for it to be a reliable reference drug.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

American and Chinese ginseng have distinct metabolic profiles that help identify their origin.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

HMBi supplementation boosts cashmere growth by affecting specific metabolic and signaling pathways in goats.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Elderly women in Northern Russia have higher anxiety and different brain energy patterns than men.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Women with both type 2 diabetes and PCOS have worse metabolic issues but milder reproductive symptoms after sleeve gastrectomy.

Salivary cytokines and the Free Androgen Index are promising non-invasive markers for diagnosing PCOS.

Age-related hearing loss involves cochlear damage and metabolic changes.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.